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Introduction
Uveitis is the most common extraarticular manifestation
of juvenile idiopathic arthritis (JIA). The nature of JIA-
associated uveitis is often insidious and asymptomatic, and
baseline predictors can aid early diagnosis of eye disease
for prompt and adequate treatment. Antihistone antibo-
dies (AHA) are among subtypes of antinuclear antibodies
(ANA) identified in children with JIA. An association
between early-onset JIA, oligoarthritis and uveitis is shown
in some studies, and we have previously shown that AHA
is a significant predictor of chronic uveitis in a Norwegian
JIA cohort. New interest for histones has emerged because
epigenetic alterations of these DNA-binding molecules
may be involved in the pathological processes of
autoimmunity.
Objectives
The aim of the study was to analyze presence of AHA in
children with JIA with and without uveitis. We also
wanted to compare AHA to previously described predic-
tors of uveitis, such as early-onset arthritis, presence of
ANA, oligoarticular ILAR category, and female gender.
Methods
Consecutive cases of JIA from defined geographical
areas of Denmark, Finland, Norway and Sweden with
disease onset in 1997 to 2000 were included and fol-
lowed for >7 years in a multi-center cohort study. Clini-
cal information on joint and eye disease was
prospectively collected in this longitudinal study aimed
to be as close to population-based as possible. ANA-IF
was analyzed twice >3 months apart in local laboratories.
Serum samples taken early after disease onset were ana-
lyzed for AHA IgG/IgM in an enzyme immunoassay
(Varelisa EIA Pharmacia Diagnostics) for the Danish and
Swedish cohort. No serum samples were available in the
Finnish cohort, and antihistone analyses in the Norwe-
gian cohort has previously been published.
Results
Uveitis occurred in 21.7 % of the 424 children with regular
ophtalmologic follow-up, among the total cohort of
500 children. In the Danish and Swedish sub-cohort of
189 children, 132 had available serum samples. Significant
predictors of chronic uveitis were onset of arthritis
≤7 years (OR 2.6 (1.5-4.7)), presence of antihistone antibo-
dies (AHA ELISA IgM/IgG >15 U/ml) (OR 4.3 (1.5-12.3)),
antinuclear antibodies (ANA IF) (OR 2.0 (1.2-3.5)), and
presence of both ANA and AHA (OR 9.1 (2.5-32.9).
Gender and oligoarticular onset category did not reach
significance as predictors of uveitis. Mean AHA ELISA
IgM/IgG was significantly higher in the children with uvei-
tis (19.2 U/ml) than in the non-uveitis group (10.3 U/ml)
(p=0.002).
Conclusion
AHA, ANA and early-onset arthritis were significant
predictors of chronic uveitis in the Nordic JIA cohort
study. The strongest predictor was presence of both
ANA and AHA. The present results in the Swedish and
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